MedPath

THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION

πŸ‡ΉπŸ‡­Thailand
Ownership
Private
Employees
-
Market Cap
-
Website

Thailand HDV Cohort

Recruiting
Conditions
HDV
First Posted Date
2022-04-28
Last Posted Date
2024-10-02
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
3152
Registration Number
NCT05350865
Locations
πŸ‡ΉπŸ‡­

Siriraj Hospital, Mahidol University, Bangkok, Thailand

πŸ‡ΉπŸ‡­

King memorial Chulalongkorn hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross - AIDS Research Centre, Bangkok, Thailand

and more 1 locations

Microneedles for Diagnosis of LTBI

Not Applicable
Terminated
Conditions
Latent Tuberculosis
Interventions
Diagnostic Test: TST vs PPD microneedle test
First Posted Date
2020-09-17
Last Posted Date
2023-03-01
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
4
Registration Number
NCT04552015
Locations
πŸ‡ΉπŸ‡­

Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Self-Assessment Tuberculin Skin Test

Completed
Conditions
Tuberculin Skin Test
Interventions
Other: The participants do not receive any intervention for this study
First Posted Date
2019-02-11
Last Posted Date
2020-07-16
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
215
Registration Number
NCT03835832
Locations
πŸ‡ΉπŸ‡­

Taksin Hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals

Phase 3
Active, not recruiting
Conditions
HIV-infected Participants With Latent TB Infection in High TB Burden Country
Interventions
Drug: Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
Drug: Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
First Posted Date
2018-12-24
Last Posted Date
2024-02-28
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
2500
Registration Number
NCT03785106
Locations
πŸ‡ΉπŸ‡­

Bhumibol Adulyadej Hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

King Chulalongkorn Memorial Hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Sanpatong Hospital, Chiang Mai, Thailand

and more 13 locations

Efficacy, Safety and Pharmacokinetics of DTG with RIF

Phase 2
Recruiting
Conditions
HIV/TB Coinfection
Interventions
Drug: DTG 50 mg OD with food
Drug: DTG 50 mg BID
First Posted Date
2018-11-06
Last Posted Date
2024-10-02
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
200
Registration Number
NCT03731559
Locations
πŸ‡ΉπŸ‡­

Infectious Disease Chiangrai Prachanukroh Hospital, Chiang Rai, Chiangrai, Thailand

πŸ‡ΉπŸ‡­

Klang Hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Bhumibol Adulyadej Hospital, Bangkok, Thailand

and more 7 locations

Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir

Phase 3
Completed
Conditions
HIV
Interventions
Drug: generic single tablet TAF/FTC/DTG
First Posted Date
2018-11-01
Last Posted Date
2024-02-28
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
170
Registration Number
NCT03727152
Locations
πŸ‡ΉπŸ‡­

Police General Hospital, Bangkok, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals

Not Applicable
Active, not recruiting
Conditions
Tuberculosis
Interventions
Diagnostic Test: XpertMTB/RIF
First Posted Date
2017-02-03
Last Posted Date
2024-02-28
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
150
Registration Number
NCT03042754
Locations
πŸ‡ΉπŸ‡­

Bamrasnaradura Institute, Nonthaburi, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Chulalongkorn University, Bangkok, Thailand

and more 1 locations

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Phase 4
Conditions
Compensated Cirrhosis
Interventions
Drug: Grazaoprevir/Elbasavir
Drug: Grazaoprevir/Elbasavir/RBV
First Posted Date
2017-01-31
Last Posted Date
2020-02-13
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
100
Registration Number
NCT03037151
Locations
πŸ‡ΉπŸ‡­

Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

RH and Adolescents

Completed
Conditions
Reproductive Health
Interventions
Other: reversible contraceptive methods
First Posted Date
2016-03-21
Last Posted Date
2016-03-21
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
77
Registration Number
NCT02713750
Locations
πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Phramongkutklao Hospital of The Royal Thai Army, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Phachomklao Hospital, Petchaburi, Thailand

and more 1 locations

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Phase 2
Completed
Conditions
HIV
Tuberculosis
Interventions
Drug: Lopinavir/r will be supplied by NHSO/GPO
Drug: Rifabutin
First Posted Date
2015-04-14
Last Posted Date
2020-02-12
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
40
Registration Number
NCT02415985
Locations
πŸ‡ΉπŸ‡­

Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

πŸ‡ΉπŸ‡­

HIV-NAT, Thai Red Cross - AIDS Research Centre, Bangkok, Thailand

πŸ‡ΉπŸ‡­

Chest Division, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

and more 1 locations
Β© Copyright 2025. All Rights Reserved by MedPath